N-Acetylprocainamide structure
|
Common Name | N-Acetylprocainamide | ||
---|---|---|---|---|
CAS Number | 32795-44-1 | Molecular Weight | 277.36200 | |
Density | 1.097g/cm3 | Boiling Point | 500ºC at 760mmHg | |
Molecular Formula | C15H23N3O2 | Melting Point | 138-140ºC(lit.) | |
MSDS | Chinese USA | Flash Point | 256.2ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of N-AcetylprocainamideN-Acetylprocainamide is a class III antiarrhythmic, which blocks K+ channels. |
Name | N-acetylprocainamide |
---|---|
Synonym | More Synonyms |
Description | N-Acetylprocainamide is a class III antiarrhythmic, which blocks K+ channels. |
---|---|
Related Catalog | |
Target |
K+ channel[1] |
In Vitro | N-Acetylprocainamide is a K+ blocker. N-Acetylprocainamide decreases the tensions induced by K+ and methacholine. The pIC50 values for N-acetylprocainamide against the contractions induced by 0.3 and 1 μM methacholine are 2.80 ± 0.03 and 2.65 ± 0.02, respectively. And such a relaxant effect of N-Acetylprocainamide is inhibited by K+ channel blockers[1]. N-Acetylprocainamide shows no effect on Na+ absorption or Cl- secretion[2]. |
References |
Density | 1.097g/cm3 |
---|---|
Boiling Point | 500ºC at 760mmHg |
Melting Point | 138-140ºC(lit.) |
Molecular Formula | C15H23N3O2 |
Molecular Weight | 277.36200 |
Flash Point | 256.2ºC |
Exact Mass | 277.17900 |
PSA | 61.44000 |
LogP | 2.18050 |
Storage condition | -20°C |
Water Solubility | soluble1%, clear, colorless to faintly yellow (1N HCl) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi: Irritant; |
Risk Phrases | 36/37/38 |
Safety Phrases | 26-36 |
RIDADR | UN 3249 |
WGK Germany | 3 |
RTECS | AE1974350 |
Packaging Group | III |
Hazard Class | 6.1(b) |
HS Code | 2924299090 |
~75% N-Acetylprocainamide CAS#:32795-44-1 |
Literature: Dang, Tuan T.; Zhu, Yinghuai; Ngiam, Joyce S. Y.; Ghosh, Subhash C.; Chen, Anqi; Seayad, Abdul M. ACS Catalysis, 2013 , vol. 3, # 6 p. 1406 - 1410 |
~80% N-Acetylprocainamide CAS#:32795-44-1 |
Literature: Ghosh, Subhash Chandra; Ngiam, Joyce S. Y.; Seayad, Abdul M.; Tuan, Dang Thanh; Chai, Christina L. L.; Chen, Anqi Journal of Organic Chemistry, 2012 , vol. 77, # 18 p. 8007 - 8015,9 Title/Abstract Full Text Show Details Ghosh, Subhash Chandra; Ngiam, Joyce S.Y.; Seayad, Abdul M.; Tuan, Dang Thanh; Chai, Christina L.L.; Chen, Anqi Journal of Organic Chemistry, 2012 , vol. 77, # 18 p. 8007 - 8015 |
~19% N-Acetylprocainamide CAS#:32795-44-1 |
Literature: CORUS PHARMA Patent: WO2005/25498 A2, 2005 ; Location in patent: Page/Page column 21 ; |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Drug-herb interaction: effect of St John's wort on bioavailability and metabolism of procainamide in mice.
Arch. Pathol. Lab. Med. 131(7) , 1094-8, (2007) St John's wort induces the activity of the cytochrome P450 enzyme system causing treatment failure because of increased metabolism of many drugs. Procainamide is metabolized by a different pathway to ... |
|
Application of computer-assisted radiotelemetry in the pharmacokinetic and pharmacodynamic modeling of procainamide and N-acetylprocainamide.
J. Pharm. Sci. 85(6) , 595-9, (1996) The cardiovascular pharmacodynamics (PD) of procainamide and N-acetylprocainamide have not been well characterized in small rodents without the presence of anesthesia or restraint. This study was unde... |
|
The discordant influences of infarct healing on the electrophysiologic effects of procainamide and N-acetylprocainamide.
J. Pharmacol. Exp. Ther. 273(1) , 315-9, (1995) Ischemic zone refractoriness and conduction delay respond differently to infarct healing and, hypothetically, may exert discordant influences on the electrophysiologic action of different classes of a... |
NAPA |
4-acetamido-N-(2-diethylaminoethyl)benzamide |
Acecainide [INN] |
MFCD00009052 |
4-acetamido-N-[2-(diethylamino)ethyl]benzamide |
N-Acetyloprokainamid |
Acecainidum |
Acekainid |
N-Acetylnovocainamide |
Acekainid [Polish] |
Acecainide |
4-acetylamino-N-(2-diethylamino-ethyl)-benzamide |
Acecainida |
N-Acetylprocainamide |